The ATMP supply chain is extremely precarious. In case of autologous therapies we are quite literally dealing with vein-to-vein logistics, in which the patient is the centre around which the supply chain is oriented, being both the provider of the starting material and receiver of the therapy. Mitigating risks, ensuring undisrupted supply and tracking the product throughout the entire process, is key.
At this roundtable a panel of experts will explore the crucial role of data sharing in the ATMP value chain and how innovative technologies can help eliminate human error.
Join us for an exclusive roundtable discussion on the fascinating world of ATMP supply chain management and don't miss this opportunity to gain invaluable insights from leaders in the field and connect with other like-minded individuals. Our CEO Jacques Parlongue will be participating in the interactive panel discussion and delve into the topic of the importance of data in relation to mitigating risks throughout the supply chain.
Interactive Panel Discussion : how do emerging technologies facilitate the ATMP supply chain?
The program will be moderated by Frank Van Gelder.
The conclusions of the roundtable will be captured in the form of a white paper.
The workflows are extremely versatile. Additionally, since the app is compatible with both tablets and computers, MyCellHub digitizes any workflow in manufacturing, material reception, quality control, or maintenance.
Get up and running quickly by starting from our library of standard unit operations. Make use of MyCellHub’s smart workflow configuration to anticipate variations in process executions.